Location: United States, California, Los Angeles
Investment Type: Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 30.03.2026 | Centivax | centivax.com | $92M | United Sta... |
Mentions in press and media 3
| Date | Title | Description |
| 31.03.2026 | Universal Vaccine Powerhouse: Centivax Raises $37 Million to Redefine Immunity | Centivax secured $37M, pushing its universal flu vaccine, Centi-Flu 01, towards Phase 2 trials. This capital also accelerates four more universal immunity programs: cancer therapy, malaria vaccine, antivenom, and Alzheimer's prevention. A s... |
| 30.03.2026 | Centivax: $37 Million Raised To Advance Universal Flu Vaccine Into Phase 2 And Expand Immunity Platform | Centivax announced it has raised $37 million in an oversubscribed financing round to accelerate the Phase 2 clinical development of its universal influenza vaccine candidate and advance additional programs toward clinical readiness. The fin... |
| 30.03.2026 | Centivax Raises $37M in Funding | Centivax, a South San Francisco, CA-based developer of a universal flu vaccine, raised $37m in funding. The round was led by Structure Fund (Oliver Mulherin & Sam Altman), with participation from Meiji Seika Pharma Co., Sigmas Group, Ke... |